CENRIFKI
Live / Allowed — Notice of allowance issued (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99191269
- Mark type
- Design + words
- Filed
- 19 May 2025
- Published for opposition
- 20 Jan 2026
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of multiple sclerosis
Owner
- Principia Biopharma Inc., Morristown, NJ, US
- Principia Biopharma Inc., Morristown, NJ, US
Prosecution history
- 17 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jan 2026 — PUBLISHED FOR OPPOSITION
- 14 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Oct 2025 — NON-FINAL ACTION E-MAILED
- 03 Oct 2025 — NON-FINAL ACTION WRITTEN
- 30 Sept 2025 — ASSIGNED TO EXAMINER
- 26 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED